These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17981146)

  • 21. Involvement of glypican-1 autoprocessing in scrapie infection.
    Löfgren K; Cheng F; Fransson LA; Bedecs K; Mani K
    Eur J Neurosci; 2008 Sep; 28(5):964-72. PubMed ID: 18717736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species-specific anti-apoptotic activity of cellular prion protein in a mouse PrP-deficient neuronal cell line transfected with mouse, hamster, and bovine Prnp.
    Wu G; Nakajima K; Takeyama N; Yukawa M; Taniuchi Y; Sakudo A; Onodera T
    Neurosci Lett; 2008 Nov; 446(1):11-5. PubMed ID: 18809465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
    Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
    J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.
    Masel J; Genoud N; Aguzzi A
    J Mol Biol; 2005 Feb; 345(5):1243-51. PubMed ID: 15644218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiprion properties of prion protein-derived cell-penetrating peptides.
    Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
    FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.
    Lau AL; Yam AY; Michelitsch MM; Wang X; Gao C; Goodson RJ; Shimizu R; Timoteo G; Hall J; Medina-Selby A; Coit D; McCoin C; Phelps B; Wu P; Hu C; Chien D; Peretz D
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11551-6. PubMed ID: 17601775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro selection of RNA aptamers against cellular and abnormal isoform of mouse prion protein.
    Sekiya S; Nishikawa F; Noda K; Kumar PK; Yokoyama T; Nishikawa S
    Nucleic Acids Symp Ser (Oxf); 2005; (49):361-2. PubMed ID: 17150783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular prion proteins of mammalian species display an intrinsic partial proteinase K resistance.
    Buschmann A; Kuczius T; Bodemer W; Groschup MH
    Biochem Biophys Res Commun; 1998 Dec; 253(3):693-702. PubMed ID: 9918789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX; Li C; Sy MS; Wong BS
    J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
    Kourie JI
    Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular prion protein signaling in serotonergic neuronal cells.
    Mouillet-Richard S; Schneider B; Pradines E; Pietri M; Ermonval M; Grassi J; Richards JG; Mutel V; Launay JM; Kellermann O
    Ann N Y Acad Sci; 2007 Jan; 1096():106-19. PubMed ID: 17405922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of prion protein (PrP) by RNA interference weakens the protective activity of wild-type PrP against copper ion and antagonizes the cytotoxicity of fCJD-associated PrP mutants in cultured cells.
    Wang ZY; Tian C; Jing YY; Gong HS; Guo Y; Shi Q; Chen C; Zhu SY; Dong XP
    Int J Mol Med; 2011 Sep; 28(3):413-21. PubMed ID: 21537833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion protein expression in bovine podocytes and extraglomerular mesangial cells.
    Amselgruber WM; Steffl M; Didier A; Märtlbauer E; Pfaff E; Büttner M
    Cell Tissue Res; 2006 Jun; 324(3):497-505. PubMed ID: 16485135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
    Havsteen BH
    J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Octapeptide repeat region and N-terminal half of hydrophobic region of prion protein (PrP) mediate PrP-dependent activation of superoxide dismutase.
    Sakudo A; Lee DC; Nishimura T; Li S; Tsuji S; Nakamura T; Matsumoto Y; Saeki K; Itohara S; Ikuta K; Onodera T
    Biochem Biophys Res Commun; 2005 Jan; 326(3):600-6. PubMed ID: 15596141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.